Organon & Co. (OGN): Total Liabilities
$12.12B
As of 2025-12-31
$12.17B
As of 2026-06-30
+0.7%
3-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $12.12B | -4.1% | 2026-02-24, Balance as of period end |
| 2024-12-31 | $12.63B | +4.1% | 2026-02-24, Balance as of period end |
| 2023-12-31 | $12.13B | +2.4% | 2025-11-10, Balance as of period end |
| 2022-12-31 | $11.85B | n/a | 2024-02-26, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Organon & Co. (OGN) | 2025-12-31 | $12.12B | -4.1% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $3.83B | +47.9% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $6.81B | +4.5% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $5.60B | +5.1% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $12.14B | +28.2% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $25.99B | -3.2% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $4.18B | +0.1% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $1.51B | +13.2% |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $6.98B | +13.9% |
Compare OGN, ONC, ELAN, PRGO side by side · Screen every company in Pharmaceutical Preparations ↗